Admera Health to Present at Precision Medicine World Conference 2020

Admera_newscenter_Ruben_blog-1024x394 Admera Health to Present at Precision Medicine World Conference 2020 Admera Health Press Uncategorized
Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, to Present at Precision Medicine World Conference 2020

Dr. Ruben Bonilla-Guerrero will present in the PMWC 2020 Clinical Diagnostics Showcase for selected organizations, to exhibit their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients.

Event | Location:  Precision Medicine World Conference 2020 | Santa Clara Convention Center
Presenter:  Ruben Bonilla-Guerrero, MD, FACMG, FAACC, Medical Director, Admera Health
Date | Time:  Friday, January 24th, 2020 | 11:30 a.m. Pacific Time
Program | Track:  Silicon Valley Program | Track 6

 

Clinical Dx Showcase:

Admera Health
Admera Health is a CLIA-certified and CAP-accredited advanced molecular diagnostics company focusing on Advancing Precision Medicine Beyond Diagnostics. Its flagship product is PGxOne™ Plus test, a comprehensive pharmacogenomics (PGx) test.

Pharmacogenomics: An Introduction To Proper Clinical Adoption
The use of Pharmacogenomics to help predict drug response is becoming more widespread. However, it is not always being used in a way that will maximize patient outcomes the way Admera Health’s PGxOne™ Plus does.

Speaker Profile:

Ruben Bonilla-Guerrero
Biography
Dr. Ruben Bonilla-Guerrero’s interests include clinical pharmacology and genetics with a focus on pharmacogenomics. At Admera Health he is responsible for the clinical content of genomic-based assays and leading the medical affairs team. Dr. Ruben Bonilla-Guerrero obtained his medical degree from the Universidad Veracruzana in Mexico. From there, he moved to the Mayo Clinic in Rochester Minnesota where he completed his training in Clinical Pharmacology and Clinical Biochemical Genetics, spending 14 years focusing on research and clinical laboratory medicine. Prior to joining Admera Health, Dr. Bonilla-Guerrero spent over nine years at Quest Diagnostics in both Laboratory Director and Medical Directors roles. Dr. Bonilla-Guerrero is board certified in Clinical Biochemical Genetics by the American Board of Clinical Pharmacology and American Board of Medical Genetics (ABMG) and in Molecular Biology by the American Society of Clinical Pathology (ASCP).


View full profile on pmwcintl.com.